Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.380 | Biomarker | group | LHGDN | Association between estrogen and androgen receptor genes and prostate cancer risk. | 18952763 | 2009 | ||||
|
0.380 | AlteredExpression | group | LHGDN | Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients. | 19107851 | 2009 | ||||
|
0.380 | Biomarker | group | LHGDN | Hormone receptor-related gene polymorphisms and prostate cancer risk in North Indian population. | 18483761 | 2008 | ||||
|
0.380 | Biomarker | group | CTD_human | Phytoestrogen exposure, polymorphisms in COMT, CYP19, ESR1, and SHBG genes, and their associations with prostate cancer risk. | 17176215 | 2006 | ||||
|
0.380 | AlteredExpression | group | LHGDN | ICI 182,780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-beta/NFkappaB crosstalk. | 16756716 | 2006 | ||||
|
0.380 | Biomarker | group | CTD_human | [Implications of estrogens and their receptors for the development and progression of prostate cancer]. | 16220300 | 2005 | ||||
|
0.380 | PosttranslationalModification | group | LHGDN | Age-dependent methylation of ESR1 gene in prostate cancer. | 15358197 | 2004 | ||||
|
0.380 | GeneticVariation | group | LHGDN | Polymorphisms of estrogen receptor alpha in prostate cancer. | 12891629 | 2003 | ||||
|
0.380 | AlteredExpression | group | BEFREE | CGA gene (coding for the alpha subunit of glycoprotein hormones) overexpression in ER alpha-positive prostate tumors. | 12180238 | 2002 | ||||
|
0.380 | AlteredExpression | group | BEFREE | Our results also suggest that ER alpha and ER beta expression status could be used to identify advanced prostate tumor patients who may respond to antiestrogen therapy. | 11280747 | 2001 |